1. Home
  2. AXGN vs QURE Comparison

AXGN vs QURE Comparison

Compare AXGN & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Axogen Inc.

AXGN

Axogen Inc.

N/A

Current Price

$55.80

Market Cap

2.6B

Sector

Health Care

ML Signal

N/A

Logo uniQure N.V.

QURE

uniQure N.V.

N/A

Current Price

$19.35

Market Cap

3.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AXGN
QURE
Founded
N/A
1998
Country
United States
Netherlands
Employees
N/A
248
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
3.1B
IPO Year
2013
2013

Fundamental Metrics

Financial Performance
Metric
AXGN
QURE
Price
$55.80
$19.35
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
13
Target Price
★ $60.09
$58.14
AVG Volume (30 Days)
★ 2.0M
1.7M
Earning Date
10-28-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 29.67
EPS
★ N/A
N/A
Revenue
★ $225,208,000.00
$13,107,000.00
Revenue This Year
$28.92
$39.49
Revenue Next Year
$28.37
$402.79
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 20.21
N/A
52 Week Low
$26.92
$8.73
52 Week High
$59.72
$51.72

Technical Indicators

Market Signals
Indicator
AXGN
QURE
Relative Strength Index (RSI) 66.73 31.36
Support Level $39.18 $13.96
Resistance Level $59.72 $26.07
Average True Range (ATR) 2.93 1.70
MACD 0.30 -0.05
Stochastic Oscillator 68.56 0.49

Price Performance

Historical Comparison
AXGN
QURE

About AXGN Axogen Inc.

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.

Share on Social Networks: